R21 malaria vaccine (Pfs230D1-based)

Pfs230D1-based malaria vaccine with Matrix-M1 adjuvant · Serum Institute of India Pvt. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R21 malaria vaccine (Pfs230D1-based), covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults [Phase 2]